PlainRecalls
FDA Drug Critical Class I Terminated

WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 30-count bottles (NDC 64727-5550-4), b) 90-count bottles (NDC 64727-5550-6), c) 100-count bottles (NDC 64727-5550-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024

Reported: September 23, 2020 Initiated: August 25, 2020 #D-1614-2020

Product Description

WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 30-count bottles (NDC 64727-5550-4), b) 90-count bottles (NDC 64727-5550-6), c) 100-count bottles (NDC 64727-5550-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024

Reason for Recall

Subpotent Drug: FDA analysis found product to be subpotent

Details

Recalling Firm
RLC Labs Inc.
Units Affected
N/A
Distribution
Nationwide in the United States
Location
Phoenix, AZ

Frequently Asked Questions

What product was recalled?
WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 30-count bottles (NDC 64727-5550-4), b) 90-count bottles (NDC 64727-5550-6), c) 100-count bottles (NDC 64727-5550-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024. Recalled by RLC Labs Inc.. Units affected: N/A.
Why was this product recalled?
Subpotent Drug: FDA analysis found product to be subpotent
Which agency issued this recall?
This recall was issued by the FDA Drug on September 23, 2020. Severity: Critical. Recall number: D-1614-2020.